We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
No fungal organisms were isolated from HIV-positive patients under antifungaldrug treatment.
2
It's certainly worth giving them a try before taking a potent antifungaldrug.
3
However, there remains a paucity of antifungaldrug treatments available to combat these fungal pathogens.
4
Our studies provide insights into the yeast-host environment interaction and identify potential antifungaldrug targets.
5
The emergence of antifungaldrug resistance is inevitable.
6
These mutations add to a growing body of research on multiple antifungaldrug targets in this organism.
7
We conclude that an antifungaldrug directed against Fba1p would have to be potent to be effective.
8
Resistance to the antifungaldrug 5-fluorocytosine was not deleterious and appeared to be slightly advantageous in vivo.
9
The emergence of antifungaldrug resistance is an evolutionary process that proceeds on temporal, spatial, and genomic scales.
10
The combined effect of the most potent compound and an antifungaldrug miconazole was investigated using the checkerboard assay.
11
Thus, the present findings support additional studies for antifungaldrug development based on plant isolated-scopoletin to treat candidiasis caused by C. tropicalis.
12
We examined the feasibility of using whole genome sequencing (WGS) for genome-wide analysis of antifungaldrug resistance in C. glabrata.
13
Although numerous studies have assessed the effectiveness of antifungaldrug and treatment regimens, most exclude patients with diabetes and examine otherwise healthy individuals.
14
Both the time course of an antifungaldrug and its absolute concentrations within tissues may differ significantly from those observed in the bloodstream.
15
We tested how replicates from diverse strains of Candida albicans, a prevalent human fungal pathogen, evolve in the commonly prescribed antifungaldrug fluconazole.
16
Nearly all of the samples from the 51 patients in facilities in New York City were resistant to fluconazole, a commonly used antifungaldrug.